tiprankstipranks
Bristol-Myers Squibb (BMY)
NYSE:BMY
US Market
BMY
Bristol-Myers Squibb
RESEARCH TOOLSreports

Bristol-Myers Squibb (BMY) Stock News & Sentiment

12,046 Followers
BMY Extends Admilparant Program, Reinforcing Its Bet on Pulmonary Fibrosis
Premium
Company Announcements
BMY Extends Admilparant Program, Reinforcing Its Bet on Pulmonary Fibrosis
4d ago
BMY
The Week That Was, The Week Ahead: Macro and Markets, Mar. 29
Premium
Market News
The Week That Was, The Week Ahead: Macro and Markets, Mar. 29
13d ago
O
DE
Bristol-Myers Squibb’s Repotrectinib DDI Study: What Investors Should Watch
Premium
Company Announcements
Bristol-Myers Squibb’s Repotrectinib DDI Study: What Investors Should Watch
14d ago
BMY
Milvexian Phase 3 Wraps Up: What Bristol-Myers Squibb Investors Should Watch Next
Premium
Company Announcements
Milvexian Phase 3 Wraps Up: What Bristol-Myers Squibb Investors Should Watch Next
14d ago
BMY
Bristol-Myers Squibb Advances BMS-986278 Through Key Heart Safety Study
Premium
Company Announcements
Bristol-Myers Squibb Advances BMS-986278 Through Key Heart Safety Study
24d ago
BMY
BMY Targets Real-World Edge for Ozanimod in Ulcerative Colitis
Premium
Company Announcements
BMY Targets Real-World Edge for Ozanimod in Ulcerative Colitis
28d ago
BMY
Balanced Outlook on BMY: Positive Mezigdomide Phase III Data Support CELMoD Platform, but Long-Term Execution Risks Warrant Hold Rating
Premium
Ratings
Balanced Outlook on BMY: Positive Mezigdomide Phase III Data Support CELMoD Platform, but Long-Term Execution Risks Warrant Hold Rating
1M ago
BMY
More BMY News >

BMY News on the Web

Does Cobenfy Have the Potential to Become a Top Drug for BMY?
Zacks
Bullish
Bristol Myers price target lowered to $67 from $68 at BofA
TipRanks News
Neutral
Bristol Myers Squibb (BMY) Rises Higher Than Market: Key Facts
Zacks
Neutral
We're exiting our position in a drug stock and initiating a stake in a more attractive rival
CNBC
Neutral
Jim Cramer's top 10 things to watch in the stock market Wednesday
CNBC
Neutral
Bristol Myers price target raised to $54 from $45 at Cantor Fitzgerald
TipRanks News
Neutral
Analysts Offer Insights on Healthcare Companies: Insmed (INSM), Vor Biopharma (VOR) and Bristol-Myers Squibb (BMY)
TipRanks News
Neutral
Gilead to Acquire Tubulis for Up to $5 Billion to Expand Cancer Drug Pipeline
Quiver Quantitative
Neutral

News Score - Last 7 Days

Positive
BMY
Sector Average
Media Buzz
This Week14 articles
Weekly Average19.75 articles
News Sentiment
This Week100%
Sector Average68%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is BMY’s Media Buzz Sentiment?
14 articles about BMY were published this week. In an average week, 19.75 articles are published.
    What is BMY’s weekly average amount of articles?
    In an average week, 19.75 articles about BMY are published.
      What is BMY’s News Sentiment?
      100% of articles about BMY were positive this week, compared to its sector average of 68%.
        Healthcare Stocks that are Trending in the News
        NBIXNeurocrine
        STAAStaar Surgical
        AORTArtivion
        OWLTOwlet
        HUMHumana
        Showing the stocks with the most bullish news sentiment over the past week